Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment
Prostate cancer (PC) is the most common cancer in men over 50 and the 4th most prevalent human malignancy. PC treatment may include surgery, androgen deprivation therapy, chemotherapy, and radiation therapy. However, the therapeutic efficacy of systemic chemotherapy is limited due to low drug solubi...
Saved in:
Main Authors: | Lital Cohen (Author), Yehuda G. Assaraf (Author), Yoav D. Livney (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective Targeting and Eradication of Various Human Non-Small Cell Lung Cancer Cell Lines Using Self-Assembled Aptamer-Decorated Nanoparticles
by: Daniel Barak, et al.
Published: (2022) -
Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer
by: Ravit Edelman, et al.
Published: (2019) -
Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours
by: Jivesh Garg, et al.
Published: (2022) -
Development and Evaluation of 1'-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy
by: Bavani Subramaniam, et al.
Published: (2021) -
Optimization of indomethacin loaded nanostructured lipid carriers
by: Pattravee Niamprem, et al.
Published: (2016)